Protagonist Therapeutics, Inc.
PTGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $97 | $187 | $126 | $124 |
| Short-Term Investments | $322 | $155 | $112 | $203 |
| Receivables | $168 | $10 | $0 | $5 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $4 | $6 | $9 |
| Total Curr. Assets | $592 | $356 | $243 | $341 |
| Property Plant & Equip (Net) | $13 | $2 | $5 | $7 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $140 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $153 | $2 | $5 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $745 | $358 | $248 | $348 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $4 | $2 |
| Short-Term Debt | $1 | $1 | $3 | $2 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $19 | $0 | $0 | $3 |
| Other Curr. Liab. | $24 | $19 | $25 | $38 |
| Total Curr. Liab. | $47 | $21 | $31 | $44 |
| LT Debt | $10 | $0 | $1 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $12 | -$0 | $0 | $0 |
| Total NC Liab. | $22 | $0 | $1 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $11 | $1 | $4 | $6 |
| Total Liabilities | $69 | $21 | $32 | $48 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$341 | -$616 | -$537 | -$409 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $1,016 | $952 | $753 | $710 |
| Total Equity | $675 | $337 | $216 | $300 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $745 | $358 | $248 | $348 |
| Net Debt | -$86 | -$186 | -$122 | -$118 |